Carr Douglas 4
4 · Century Therapeutics, Inc. · Filed Jun 15, 2026
Research Summary
AI-generated summary of this filing
Century Therapeutics (IPSC) SVP Finance Douglas Carr Sells 1,654 Shares
What Happened
Douglas Carr, SVP Finance & Operations at Century Therapeutics (IPSC), disposed of 1,654 shares on 2026-06-12 at $2.23 per share, generating proceeds of $3,692. The sale is reported as a disposition (code S) and was done to satisfy tax withholding obligations related to the vesting of restricted stock units.
Key Details
- Transaction date: 2026-06-12; Form 4 filed: 2026-06-15.
- Type: Sale (S) — 1,654 shares at $2.23 per share; total proceeds $3,692.
- Shares owned after transaction: Not specified in the provided filing.
- Footnote: F1 — sale was automatic to cover tax withholding for RSU vesting and not at the reporting person's discretion.
- No 10b5-1 plan or other special trading program is indicated in the filing excerpt.
Context
Sales made solely to cover tax withholding on vested awards are routine and are generally not considered a strong directional signal about an insider’s view of the company, especially given the small dollar value here (~$3.7k). Retail investors typically weigh purchases more heavily than such routine, administrative sales.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-06-12$2.23/sh−1,654$3,692→ 505,094 total
Footnotes (1)
- [F1]The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.